Persistence of norfluoxetine in marine mussels

Mar Pollut Bull. 2023 Dec:197:115763. doi: 10.1016/j.marpolbul.2023.115763. Epub 2023 Nov 11.

Abstract

The concentration of pharmaceuticals in coastal waters is tending towards increasing due to a shift of the human population into coastal zones. In parallel, the number of prescriptions of antidepressants, mainly selective serotonin reuptake inhibitors (SSRI), is constantly growing. Most of the SSRI is metabolised into active compounds; for instance, norfluoxetine (NFLU) is the main active metabolite of fluoxetine. In this study, we tested the bioaccumulation and depuration of NFLU in Mytilus trossulus at two environmentally relevant concentrations (100 and 500 ng/L, after six days of exposure and five days of depuration at 10 °C). The concentration of NFLU in the mussels' tissue seems not to be directly proportional to the exposure concentration. The levels of NFLU in the mussels' tissues after the depuration period were comparable to the levels detected at the end of exposure. This indicates that NFLU is not efficiently removed by the mussels and points to a potential risk for consumers of such marine organisms.

Keywords: Bioaccumulation; Depuration; Ecotoxicology of mussels; Norfluoxetine.

MeSH terms

  • Animals
  • Fluoxetine
  • Humans
  • Mytilus* / metabolism
  • Seafood / analysis
  • Water Pollutants, Chemical* / analysis

Substances

  • norfluoxetine
  • Fluoxetine
  • Water Pollutants, Chemical